Optical Control of Adenosine A_2A Receptor Using Istradefylline Photosensitivity

Area of Science:

• Photochemistry
• Pharmacology
• Neuroscience

Background:

• Adenosine A_2A receptors (A_2AR) are therapeutic targets for neurodegenerative diseases and cancer.
• Developing selective ligands for A_2AR is crucial due to their widespread expression.
• Photopharmacology offers precise spatiotemporal control over biological targets using light-sensitive molecules.

Purpose of the Study:

• To investigate the light sensitivity of the FDA-approved antagonist istradefylline.
• To explore the potential of istradefylline as a photopharmacological tool for A_2AR modulation.
• To demonstrate light-induced control over A_2AR signaling.

Main Methods:

• Utilized photochemistry, cellular assays, and in vivo studies in zebrafish.
• Investigated the photochemical properties of istradefylline under near-UV and UV light.
• Assessed the impact of light exposure on istradefylline's antagonistic activity in A_2AR-expressing cells.

Main Results:

• Istradefylline undergoes rapid trans-to-cis isomerization and photocycloaddition upon UV light exposure.
• UV light exposure leads to a time-dependent decrease in istradefylline's A_2AR antagonistic activity.
• Demonstrated real-time optical control of A_2AR signaling in living cells and zebrafish.

Conclusions:

• Istradefylline functions as a photoinactivatable A_2AR antagonist.
• This photoinactivatable property enables its use in photopharmacological studies.
• Provides a novel method for precise optical control of A_2AR signaling in biological systems.